ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2024

Abstract Number: 0978

Associations of Fire Smoke and Other Pollutants with Incident Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease

Vanessa Kronzer1, Yangyuna Yang2, Punyasha Roul3, James Crooks4, Cynthia Crowson1, John Davis1, Jeffrey Sparks5, Jeffrey Pierce6, Katelyn O'Dell7, Sauer brian8, grant Cannon9, Joshua Baker10, Ted Mikuls2 and Bryant England2, 1Mayo Clinic, Rochester, MN, 2University of Nebraska Medical Center, Omaha, NE, 3UNMC, Omaha, NE, 4National Jewish Health, Denver, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA, 6Colorado State University, Fort Collins, 7George Washington University, Washington DC, 8Salt Lake City VA/University of Utah, Salt Lake City, UT, 9University of Utah and Salt Lake City VA, Salt Lake City, UT, 10Department of Medicine, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2024

Keywords: Environmental factors, Epidemiology, interstitial lung disease, rheumatoid arthritis, Smoking

Session Information

Date: Sunday, November 17, 2024

Title: Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Wildfires have burned increasing acreage in the United States (US) since the 1980s, releasing record and alarming levels of particulate matter smaller than 2.5 microns (PM2.5,). In addition, respiratory tract irritation is associated with rheumatoid arthritis (RA). Therefore, we aimed (1) to determine the associations between fire smoke PM2.5 and other pollutant exposures with the risk of RA and RA-associated interstitial lung disease (RA-ILD) and (2) to identify the timing of any such associations.

Methods: In this case-control study using national Veterans Affairs (VA) data, we identified incident RA and RA-ILD cases using validated algorithms (positive predictive values >90% and 81%, respectively). We matched each case to up to 10 controls on age, gender, and VA enrollment year. Seropositivity was based on electronic health record laboratory data. The primary exposure was mean daily fire smoke PM2.5 at least one year before RA diagnosis, obtained from a fused product of ground pollutant monitoring and satellite imagery. Other pollutants included carbon monoxide, nitrogen oxides (NOx), ozone, overall PM2.5, PM10, and sulfur dioxide (SO2). Pollutant exposures were also evaluated by time periods before RA (1-3 years, 3-5 years, >5 years). We used conditional logistic regression models to estimate adjusted odds ratios (aOR) with 95% confidence intervals (CI) for incident RA and RA-ILD, adjusted for age, gender, enrollment year, duration of pollutant exposures, race and ethnicity, body mass index, and smoking status.

Results: We identified 9,701 incident RA cases (mean age 65, 86% male), including 531 RA-ILD cases (mean age 69, 91% male), and 68,852 matched controls (Table 1). Fire smoke PM2.5 was not associated with RA overall (aOR 1.07, 95% CI 0.92-1.23, Table 2), but was associated in the 1-5 years before RA onset (aOR 1.13, 95% CI 1.02-1.26, Figure 1). Fire smoke PM2.5 was associated with RA-ILD (aOR 1.98, 95% CI 1.08-3.62 per 1 µg/m3). Increased levels of NOx were also associated with RA (aOR 1.16, 95% CI 1.06-1.27 for highest vs. lowest quartile, Table 2). Ozone (aOR 1.19, 95% CI 1.06-1.34) and PM10 (aOR 1.25, 95% CI 1.10-1.43) were associated with seronegative, but not seropositive, RA. Carbon monoxide, overall PM2.5, and SO2 were not, or negatively, associated with risk of RA and RA-ILD (Table 2).

Conclusion: Increased levels of fire smoke PM2.5 are associated with RA-ILD, while fossil fuel-related NOx, ozone, and PM10 are associated with RA. Therefore, improved pollutant monitoring infrastructure and prevention strategies are needed.

Supporting image 1

Supporting image 2

Supporting image 3

Figure 1. Forest plot depicting associations of fire smoke PM2.5 with risk of RA by exposure time period. Models are per 1 µg/m3 increase in PM2.5 and adjusted for age, sex, enrollment, duration of pollutant exposure data, race and ethnicity, body mass index, and smoking status. RA = rheumatoid arthritis.

Disclosures: V. Kronzer: None; Y. Yang: None; P. Roul: None; J. Crooks: None; C. Crowson: None; J. Davis: Girihlet, 10, NLC Health Ventures, 10, Pfizer, 5, Remission Medical, 10; J. Sparks: Boehringer-Ingelheim, 2, 5, Bristol-Myers Squibb(BMS), 2, 5, Gilead, 2, Janssen, 2, Pfizer, 2, UCB, 2; J. Pierce: None; K. O'Dell: None; S. brian: None; g. Cannon: None; J. Baker: CorEvitas, LLC, 2, Cumberland Pharma, 2, Formation Bio, 2, Horizon, 5; T. Mikuls: Elsevier, 9, Horizon Therapeutics, 2, 5, Pfizer, 2, Sanofi, 2, UCB Pharma, 2, Wolters Kluwer Health (UpToDate), 9; B. England: Boehringer-Ingelheim, 5.

To cite this abstract in AMA style:

Kronzer V, Yang Y, Roul P, Crooks J, Crowson C, Davis J, Sparks J, Pierce J, O'Dell K, brian S, Cannon g, Baker J, Mikuls T, England B. Associations of Fire Smoke and Other Pollutants with Incident Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/associations-of-fire-smoke-and-other-pollutants-with-incident-rheumatoid-arthritis-and-rheumatoid-arthritis-associated-interstitial-lung-disease/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-of-fire-smoke-and-other-pollutants-with-incident-rheumatoid-arthritis-and-rheumatoid-arthritis-associated-interstitial-lung-disease/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology